Literature DB >> 4164149

Immunosuppressive therapy of chronic renal disease.

A F Michael, R L Vernier, K N Drummond, J I Levitt, R C Herdman, A J Fish, R A Good.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4164149     DOI: 10.1056/NEJM196704132761501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  The morphological and clinical course of the different forms of glomerulonephritis.

Authors:  H Fishbach; A Bohle; D Meyer; H H Edel; U Frotscher; R Kluthe; D Renner; K Rinsche; F Scheler
Journal:  Klin Wochenschr       Date:  1976-02-01

2.  Henoch-Schönlein purpura occurring in three members of a family.

Authors:  W S Lofters; G F Pineo; K H Luke; R G Yaworsky
Journal:  Can Med Assoc J       Date:  1973-07-07       Impact factor: 8.262

3.  Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.

Authors:  C N Lam; G C Arneil
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

4.  Cryoglobulins in vasculitis.

Authors:  J J Cream
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

5.  Management of the nephrotic syndrome.

Authors:  G C Arneil
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

6.  Remission in Goodpasture's syndrome: report of two patients treated by immunosuppression and review of the literature.

Authors:  A Seaton; J M Meland; N L Lapp
Journal:  Thorax       Date:  1971-11       Impact factor: 9.139

7.  [Clinical and prognostic significance of histological classification in glomerulonephritis].

Authors:  E Renner; H Edel; J Eigler; E Buchborn
Journal:  Klin Wochenschr       Date:  1969-07-15

8.  Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

Authors:  K N Drummond; D A Hillman; J H Marchessault; W Feldman
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

9.  Treatment of acute myelopathy in systemic lupus erythematosus with plasma exchange and immunosuppression.

Authors:  D I Slovick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

10.  Extremembranous deposits and "membranous" glomerulonephritis. Their fine structure, development, and correlation.

Authors:  P Rossmann; J Jirka; L Hradcová
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.